GENIUS SPORTS LTD (GENI)

GG00BMF1JR16 - Common Stock

5.71  +0.06 (+1.06%)

After market: 5.71 0 (0%)

Fundamental Rating

2

GENI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 135 industry peers in the Hotels, Restaurants & Leisure industry. GENI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GENI is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

GENI had negative earnings in the past year.
In the past year GENI had a positive cash flow from operations.

1.2 Ratios

GENI's Return On Assets of -11.03% is on the low side compared to the rest of the industry. GENI is outperformed by 87.31% of its industry peers.
With a Return On Equity value of -14.93%, GENI perfoms like the industry average, outperforming 40.30% of the companies in the same industry.
Industry RankSector Rank
ROA -11.03%
ROE -14.93%
ROIC N/A
ROA(3y)-34.2%
ROA(5y)N/A
ROE(3y)-43.98%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 16.72%, GENI is not doing good in the industry: 88.81% of the companies in the same industry are doing better.
GENI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

GENI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GENI has been increased compared to 1 year ago.
The debt/assets ratio for GENI has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.28 indicates that GENI is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.28, GENI is doing good in the industry, outperforming 64.93% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that GENI is not too dependend on debt financing.
GENI has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. GENI outperforms 92.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.28
ROIC/WACCN/A
WACC8.43%

2.3 Liquidity

GENI has a Current Ratio of 1.34. This is a normal value and indicates that GENI is financially healthy and should not expect problems in meeting its short term obligations.
GENI has a better Current ratio (1.34) than 66.42% of its industry peers.
GENI has a Quick Ratio of 1.34. This is a normal value and indicates that GENI is financially healthy and should not expect problems in meeting its short term obligations.
GENI has a better Quick ratio (1.34) than 70.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.34

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.11% over the past year.
The Revenue has grown by 21.08% in the past year. This is a very strong growth!
EPS 1Y (TTM)61.11%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q80.95%
Revenue 1Y (TTM)21.08%
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2Q20.77%

3.2 Future

The Earnings Per Share is expected to grow by 51.63% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 18.07% on average over the next years. This is quite good.
EPS Next Y62.99%
EPS Next 2Y46.7%
EPS Next 3Y51.63%
EPS Next 5YN/A
Revenue Next Year15.18%
Revenue Next 2Y15.58%
Revenue Next 3Y17.85%
Revenue Next 5Y18.07%

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GENI. In the last year negative earnings were reported.
Also next year GENI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GENI is valued expensively inside the industry as 83.58% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 211.24

4.3 Compensation for Growth

GENI's earnings are expected to grow with 51.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.7%
EPS Next 3Y51.63%

0

5. Dividend

5.1 Amount

GENI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GENIUS SPORTS LTD

NYSE:GENI (3/28/2024, 4:00:26 PM)

After market: 5.71 0 (0%)

5.71

+0.06 (+1.06%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.30B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.03%
ROE -14.93%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 16.72%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.34
Quick Ratio 1.34
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)61.11%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y62.99%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)21.08%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y